Heartbeam Inc已启动一项试点研究，旨在评估其首创的按需12导联心电图贴片在临床环境外检测心肌缺血的有效性。这项研究标志着远程心脏监测技术迈出了重要一步，有望使患者能够在日常活动中便捷地进行医疗级心电图检查。该贴片的设计目标是提供与传统12导联心电图相当的诊断数据，同时具备可穿戴设备的便利性和可及性。如果试点结果积极，该技术可能为心脏病患者，尤其是那些需要持续监测心肌缺血风险的患者，提供一种变革性的家庭监测解决方案。
Heartbeam Inc已启动一项试点研究，旨在评估其首创的按需12导联心电图贴片在临床环境外检测心肌缺血的有效性。这项研究标志着远程心脏监测技术迈出了重要一步，有望使患者能够在日常活动中便捷地进行医疗级心电图检查。该贴片的设计目标是提供与传统12导联心电图相当的诊断数据，同时具备可穿戴设备的便利性和可及性。如果试点结果积极，该技术可能为心脏病患者，尤其是那些需要持续监测心肌缺血风险的患者，提供一种变革性的家庭监测解决方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.